FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. (Q51016978)

27 March 2018

title

FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study. (English)

1 reference

27 March 2018

0 references

0 references

17

1 reference

27 March 2018

Henna Tyynismaa

25

1 reference

27 March 2018

Katrin Õunap

13

object named as

Katrin Õunap

1 reference

27 March 2018

Kirsi H Pietiläinen

3

0 references

Hannele Yki-Järvinen

21

object named as

Hannele Yki-Järvinen

1 reference

27 March 2018

20

Aila Rissanen

1 reference

27 March 2018

Ksenia Sevastianova

5

object named as

Ksenia Sevastianova

1 reference

27 March 2018

author name string

Anu Suomalainen

1

1 reference

27 March 2018

Jenni M Elo

2

1 reference

27 March 2018

Anna H Hakonen

4

1 reference

27 March 2018

Mari Korpela

6

1 reference

27 March 2018

Pirjo Isohanni

7

1 reference

27 March 2018

Sanna K Marjavaara

8

1 reference

27 March 2018

Tiina Tyni

9

1 reference

27 March 2018

Sari Kiuru-Enari

10

1 reference

27 March 2018

Helena Pihko

11

1 reference

27 March 2018

Niklas Darin

12

1 reference

27 March 2018

Leo A J Kluijtmans

14

1 reference

27 March 2018

Anders Paetau

15

1 reference

27 March 2018

Jana Buzkova

16

1 reference

27 March 2018

Johanna Annunen-Rasila

18

1 reference

27 March 2018

Johanna Uusimaa

19

1 reference

27 March 2018

Michio Hirano

22

1 reference

27 March 2018

Mar Tulinius

23

1 reference

27 March 2018

Jan Smeitink

24

1 reference

27 March 2018

publication date

3 August 2011

1 reference

27 March 2018

published in

Lancet Neurology

1 reference

27 March 2018

volume

10

1 reference

27 March 2018

issue

9

1 reference

27 March 2018

page(s)

806-818

1 reference

27 March 2018

EFNS guidelines on the molecular diagnosis of mitochondrial disorders

cites work

1 reference

12 December 2020

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

1 reference

12 December 2020

Multisystem manifestations of mitochondrial disorders

1 reference

12 December 2020

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease

1 reference

12 December 2020

Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients

1 reference

12 December 2020

Current issues regarding treatment of mitochondrial fatty acid oxidation disorders

1 reference

12 December 2020

FGF21 is an Akt-regulated myokine

1 reference

12 December 2020

Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride

1 reference

12 December 2020

Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile

1 reference

12 December 2020

Mitochondrial myopathy induces a starvation-like response

1 reference

12 December 2020

Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.

1 reference

12 December 2020

Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease

1 reference

12 December 2020

Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states.

1 reference

12 December 2020

Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders

1 reference

12 December 2020

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

1 reference

12 December 2020

Selection and interpretation of diagnostic tests and procedures. Principles and applications.

1 reference

12 December 2020

Prevalence of mitochondrial DNA disease in adults

1 reference

12 December 2020

Biomarkers for mitochondrial respiratory chain disorders

1 reference

12 December 2020

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein

1 reference

12 December 2020

Liver fat but not other adiposity measures influence circulating FGF21 levels in healthy young adult twins.

1 reference

12 December 2020

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects

1 reference

12 December 2020

Minimum birth prevalence of mitochondrial respiratory chain disorders in children

1 reference

12 December 2020

Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin

1 reference

12 December 2020

Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis

1 reference

12 December 2020

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

1 reference

12 December 2020

A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells

1 reference

12 December 2020

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

1 reference

12 December 2020

Mitochondrial complex I: structure, function and pathology

1 reference

12 December 2020

Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa.

1 reference

12 December 2020

Pathogenic mitochondrial DNA mutations are common in the general population

1 reference

12 December 2020

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

1 reference

12 December 2020

FGF-21 as a novel metabolic regulator

1 reference

12 December 2020

Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease.

1 reference

12 December 2020

10.1016/S1474-4422(11)70155-7

Identifiers

DOI

1 reference

27 March 2018

PMC publication ID

7568343

0 references

1 reference

27 March 2018